{"id":125538,"date":"2025-10-16T09:43:11","date_gmt":"2025-10-16T09:43:11","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/125538\/"},"modified":"2025-10-16T09:43:11","modified_gmt":"2025-10-16T09:43:11","slug":"illuminas-constellation-tech-a-star-in-genedx-pilot","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/125538\/","title":{"rendered":"Illumina&#8217;s constellation tech a star in Genedx pilot"},"content":{"rendered":"<p>Genedx LLC partnered with Illumina Inc. to test whether Illumina&#8217;s constellation map read technology could shed light on hard-to-detect variants that appear in rare diseases. Constellation met or exceeded the ability of other sequencing methods to detect variants implicated in multiple disorders and worked across a range of sample types, a study presented at the American Society for Human Genetics (ASHG) Annual Meeting in Boston on Oct. 15 found.<\/p>\n<p><a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/85-bioworld-medtech\" rel=\"nofollow noopener\" target=\"_blank\">BioWorld MedTech<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/153-clinical\" rel=\"nofollow noopener\" target=\"_blank\">Clinical<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/254-neonatal-pediatrics\" rel=\"nofollow noopener\" target=\"_blank\">Neonatal\/pediatrics<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/325-diagnostics\" rel=\"nofollow noopener\" target=\"_blank\">Diagnostics<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/401-u-s\" rel=\"nofollow noopener\" target=\"_blank\">U.S.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Genedx LLC partnered with Illumina Inc. to test whether Illumina&#8217;s constellation map read technology could shed light on&hellip;\n","protected":false},"author":2,"featured_media":125539,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[272],"tags":[23579,12771,74438,8626,18,76130,67882,458,6872,19,76129,17,12585,61262,67883,76131,133,3070],"class_list":{"0":"post-125538","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-bioworld-medtech","9":"tag-clinical","10":"tag-constellation","11":"tag-diagnostics","12":"tag-eire","13":"tag-exome","14":"tag-genedx","15":"tag-genetics","16":"tag-genomics","17":"tag-ie","18":"tag-illumina-inc","19":"tag-ireland","20":"tag-medtech","21":"tag-neonatal-pediatrics","22":"tag-newborn-screening","23":"tag-novaseq","24":"tag-science","25":"tag-u-s"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/125538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=125538"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/125538\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/125539"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=125538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=125538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=125538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}